About Remidex Pharma Private Limited
Data last updated:
Remidex Pharma Private Limited is a private limited company based in Bengaluru, Karnataka, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 15 June 1981 and has been in existence for over 45 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24231KA1981PTC004260. Its GSTIN is 29AAACR7006C1ZP (Karnataka).
The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹3 Cr. It is led by directors including Nilima Dayanand Rao (Managing Director) and Ishaan Pejavar Rao.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 249 250 147&148 6th Main 2nd Stage Peenya Industrial Estate, Bengaluru, Karnataka, India – 560058.
As per the financials filed for FY 2025, the company reported a revenue of ₹24.56 Cr, a decline of 22% compared to the previous year. For the same year it recorded a net loss of ₹1.34 Cr (net margin -5.4%) and EBITDA of -₹3.64 Lakh (EBITDA margin -0.1%). Revenue has declined at a compounded annual rate (CAGR) of 11% over three years and 8% over five years.
The company has about 123 employees on its provident fund (EPFO) records.
The company is associated with 2 brands: Remidex Pharma and Humbing Ethicals. As per MCA filings, the company has open charges of ₹4 Cr and satisfied charges of ₹15.26 Cr on record. Court records list 26 cases involving the company, including 7 filed by the company and 10 filed against it; 4 cases are pending. The company has 4 deals on record (4 secondary share transfers); the latest was in March 2020. Its 10 peer companies in the Pharma industry (Contract Research, Formulations) are compared by revenue, 5 larger and 5 smaller; the largest is Evinz Drugs Private Limited. The company has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 22 overdue payments to 9 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website remidexpharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressB – 249 250 147&148 6th Main 2nd Stage Peenya Industrial Estate, Bengaluru, Karnataka, India – 560058
- IndustryPharma, Drug Formulation & Development, Pharma Contract R&D
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Remidex Pharma Private Limited
The main business activity of Remidex Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Remidex Pharma Private Limited FY 2025 filings available
Remidex Pharma Private Limited reported revenue of ₹24.56 Cr (down 22% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Remidex Pharma Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 8% over five years, including a 22% fall in the latest year. EBITDA rose 88% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Remidex Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹3.64 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹1.34 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Remidex Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -5.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Remidex Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Remidex Pharma Private Limited
Remidex Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Contract Research, Formulations). Revenue, net profit, margin and growth of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Evinz Drugs Private Limited | •••• | •••• | •••• | •••• | - | Hyderabad, Telangana, India |
| Vats Biotech Private Limited | •••• | •••• | •••• | •••• | - | Jamshedpur, Jharkhand, India |
| Saviour Wellness Private Limited | •••• | •••• | •••• | •••• | - | New Delhi, Delhi, India |
| Strategic Marketing Solutions and Research Centre Private Limited | •••• | •••• | •••• | •••• | 177 | Kolkata, West Bengal, India |
| Pharlink Labs Private Limited | •••• | •••• | •••• | •••• | 36 | Chennai, Tamil Nadu, India |
| Remidex Pharma Private Limited this company | •••• | •••• | •••• | •••• | - | Bengaluru, Karnataka, India |
| Carewell Steuart Pharma Private Limited | •••• | •••• | •••• | •••• | 14 | Tiruvallur, Tamil Nadu, India |
| MRHM Pharma Private Limited | •••• | •••• | •••• | •••• | - | Bangalore North, Karnataka, India |
| Sunberg Life Sciences Private Limited | •••• | •••• | •••• | •••• | 53 | Chennai, Tamil Nadu, India |
| Axon Drugs Private Limited | •••• | •••• | •••• | •••• | 72 | Chennai, Tamil Nadu, India |
| Osaka Pharmaceuticals Private Limited | •••• | •••• | •••• | •••• | - | Vadodara, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Remidex Pharma by revenue in the Pharma industry (Contract Research, Formulations), from the latest filed financials of each company. Revenue, net profit, margin and growth of each peer are in the company report.
Auditor Details of Remidex Pharma Private Limited
Remidex Pharma Private Limited is audited by KIRTANE & PANDIT LLP for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| KIRTANE & PANDIT LLP | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Remidex Pharma Private Limited
Remidex Pharma has 3 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ishaan Pejavar Rao | Director | 24 Oct 2018 | 7 Years 11 Months | Current |
| Nandan Pejavar Rao | Director | 24 Oct 2018 | 7 Years 11 Months | Current |
| Nilima Dayanand Rao | Managing Director | 24 Jan 2017 | 9 Years 8 Months | Current |
Ownership and Shareholding of Remidex Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Remidex Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Apr 2006 | Canara Bank | ₹4 Cr | Open |
| 21 Aug 2019 | Others | ₹6 Cr | Satisfied |
| 20 Jul 2018 | Canara Bank | ₹31 Lakh | Satisfied |
| 29 Jan 2005 | Kotak Mahindra Bank Ltd | ₹1.95 Cr | Satisfied |
| 29 Jan 2005 | Kotak Mahindra Bank Limited | ₹3.35 Cr | Satisfied |
Total charge records: 9 View all charges
Deals & Funding of Remidex Pharma Private Limited
Remidex Pharma Private Limited has 4 deals on record (4 secondary share transfers); the latest was in March 2020.
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2020 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: an individual |
| Mar 2012 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Sep 2009 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: an individual |
| Nov 2008 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
Full deal history
All 4 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Remidex Pharma Private Limited
Remidex Pharma Private Limited has 26 court cases on record: 7 filed by Remidex Pharma, 10 filed against it, 9 where it is another party. 4 cases are pending and 22 are disposed. Status as checked between 29 Sep 2026 and 05 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 16 | 3 | 3 |
| District courts | 9 | 6 | 1 |
| Supreme Court | 1 | 1 | 0 |
Cases on record (5 of 26)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai City Civil Court, Maharashtra | Interim or miscellaneous application | Filed against the company by Resonance Specialties Limited | Disposed |
| District court, BENGALURU, Karnataka | Civil suit | Filed by the company against Om Logistics Limited | Disposed |
| High Court of Karnataka | Writ petition | Company is another party | Pending |
| District court, Patna, Bihar | Court case (Cr. Case Complaint (P)) | Filed against the company by an individual | Pending |
| Bombay High Court | Writ petition | Filed by the company against State of Maharashtra and 3 Ors | Pending |
Full case history
All 26 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Remidex Pharma Private Limited
Remidex Pharma Private Limited has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 22 overdue payments to 9 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 9)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| Award Packaging Private Limited | •••• | •••• | •••• |
| Karan Plascon Private Limited | •••• | •••• | •••• |
| Sunshine Organics Pvt Ltd | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 2 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Associated Brands with Remidex Pharma Private Limited
Remidex Pharma operates two associated brands: Remidex Pharma and Humbing Ethicals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures high-quality pharmaceutical and nutraceutical products, including tablets, capsules, liquids, and premixes. | remidexpharma.com | |
| Potato farming, grain marketing, and equipment services in Maine. | humbingethicals.com |
Employees and EPFO Compliance at Remidex Pharma Private Limited
Remidex Pharma Private Limited has a workforce of 123 employees as of Mar 21, 2025.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Remidex Pharma Private Limited
Remidex Pharma has one previous CIN (Corporate Identification Number): U02423KA1981PTC004260. The current CIN is U24231KA1981PTC004260, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24231KA1981PTC004260 | Current |
| U02423KA1981PTC004260 | Previous |
Recent Activity on Remidex Pharma Private Limited
Remidex Pharma Private Limited has 12 board changes on record since 2008: 3 appointments and 9 cessations. The latest: Mohini Dayanand Rao ceased to be Director on 11 Jun 2020.
23 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Remidex Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Remidex Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Remidex Pharma Private Limited
Remidex Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAACR7006C1ZP | Karnataka | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Remidex Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Remidex Pharma Private Limited
Remidex Pharma is an active private limited company based in Bengaluru, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 15 June 1981 (45+ years old) and is registered under CIN U24231KA1981PTC004260.
Remidex Pharma reported revenue of ₹24.56 Cr for FY 2025 (down 22% YoY).
Remidex Pharma has 3 current directors:
- Nilima Dayanand Rao - Managing Director
- Ishaan Pejavar Rao - Director
- Nandan Pejavar Rao - Director
Remidex Pharma reported a net loss of ₹1.34 Cr (net margin -5.4%) and EBITDA of -₹3.64 Lakh (EBITDA margin -0.1%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Remidex Pharma is 11% over three years and -8% over five years. In the latest year (FY 2025) revenue fell 22%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Remidex Pharma is 29AAACR7006C1ZP, registered in Karnataka.
The CIN (Corporate Identification Number) of Remidex Pharma is U24231KA1981PTC004260. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Remidex Pharma has 26 court cases on record: 7 filed by the company and 10 filed against it. 4 are pending. Most are in the high courts.
Remidex Pharma was incorporated on 15 June 1981, making it 45+ years old. It is registered with the Registrar of Companies, Bangalore.
Remidex Pharma has 4 deals on record (4 secondary share transfers); the latest was in March 2020.
The peers of Remidex Pharma by revenue are Evinz Drugs Private Limited, Vats Biotech Private Limited, Saviour Wellness Private Limited, Strategic Marketing Solutions and Research Centre Private Limited, Pharlink Labs Private Limited and 5 more, all in the Pharma industry (Contract Research, Formulations).
Mohini Dayanand Rao ceased to be Director on 11 Jun 2020. Ishaan Pejavar Rao ceased to be Additional Director on 24 Sep 2019. Nandan Pejavar Rao ceased to be Additional Director on 24 Sep 2019. Remidex Pharma has 12 board changes on record in total.